+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Branded Generics Market - Global Forecast 2026-2032- Product Image
Branded Generics Market - Global Forecast 2026-2032- Product Image
New

Branded Generics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 185 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5896414
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The branded generics market is pivotal for pharmaceutical companies and healthcare stakeholders, offering accessible therapies that combine trusted branding with affordability. Its evolution reflects a strategic response to rising global healthcare demands, regulatory pressures, and the ongoing pursuit of sustainable value in medicine procurement.

Market Snapshot: Branded Generics Market Overview

The Branded Generics Market expanded from USD 567.75 billion in 2025 to USD 652.14 billion in 2026, demonstrating a robust compound annual growth rate (CAGR) of 15.15%. Projected to reach USD 1.52 trillion by 2032, this sustained market momentum highlights the strong demand for cost-efficient branded medicines. Growth is driven by shifting procurement practices, advancing healthcare systems, and a rising preference for therapies that deliver both economic value and reliable therapeutic outcomes, especially as global pricing and reimbursement models continue to evolve.

Scope & Segmentation

  • Dosage Forms: Injections (intramuscular, intravenous, subcutaneous); liquids (suspensions, syrups); tablets and capsules (extended and immediate release); and topicals (creams, gels, ointments) are analyzed to reflect adoption trends and preference drivers across clinical and consumer segments.
  • Therapeutic Areas: Coverage spans anti-infectives, cardiovascular treatments, central nervous system agents, gastrointestinal solutions, and pain management medications. The breadth across chronic and acute indications highlights the diverse impact of branded generics on public health outcomes.
  • Applications: Both human and animal health sectors are addressed. Animal health segmentation includes companion animals (cats, dogs) and livestock, emphasizing the growing importance of veterinary generics for healthcare providers and agriculture.
  • Distribution Channels: Hospital and retail pharmacies, drug stores, and online pharmacies—including both app- and web-based platforms—reflect evolving buying power, logistics innovations, and new patient engagement strategies that support differentiated channel growth.
  • Regional Scope: Analysis includes the Americas, Europe/Middle East & Africa, and Asia-Pacific. Each brings unique regulatory structures, procurement environments, and commercial incentives that shape market entry and positioning strategies.
  • Technological Dynamics: Digital health, serialization to ensure product security, and emerging supply chain technologies are evaluated for their roles in driving operational resilience and competitive differentiation within the sector.

Key Takeaways for Industry Leaders

  • Manufacturers utilize branded generics to maximize product lifecycles and sustain revenue flows, especially in price-sensitive landscapes where regulatory constraints are complex.
  • Payers and providers increasingly look for medicines that balance efficacy with supply reliability and procurement efficiency, which elevates the strategic role of branded generics in formulary decision-making and payer contracting.
  • Regional differences necessitate tailored commercial models: Asia-Pacific emphasizes localized production, whereas Europe and the Americas favor advanced negotiation and adaptive distribution networks responsive to diverse market needs.
  • Integrating investments in manufacturing quality, generating real-world evidence, and leveraging digital engagement tools enhances the value proposition for prescribers, payers, and patients.
  • Sustainability, transparency, and ESG alignment are influencing procurement and tender decisions. Stakeholders are seeking brands with visible commitments to responsible operations.
  • Developing patient support resources and facilitating direct engagement through digital platforms further distinguish branded generics, supporting superior adherence and premium product positioning.

Tariff Impact on Sourcing and Supply Chains

Changes to global tariff structures are reshaping procurement strategies, supplier partnerships, and distribution models across the branded generics sector. To protect margins and secure continuous supply, manufacturers are accelerating supplier diversification, investing in nearshoring, and adopting flexible inventory management. Regional manufacturing centers are gaining strategic importance, enabling companies to navigate trade barriers and mitigate logistics challenges that can disrupt product flow in volatile markets.

Methodology & Data Sources

This analysis integrates structured regulatory reviews, detailed market and policy assessments, and direct interviews with industry experts, supply chain professionals, and commercial executives. Triangulation of findings via segment mapping and scenario-based analysis ensures insights are both actionable and reliable, grounded in the most current market intelligence.

Why This Report Matters

  • Supports strategic planning and risk mitigation for executives evaluating market entry or expansion options in branded generics.
  • Delivers actionable insights on optimizing quality, sourcing, and digital initiatives—critical levers for maintaining competitiveness within evolving procurement environments.
  • Equips commercial teams to tailor supply chain and distribution approaches to shifting regional regulations and market structures.

Conclusion

Branded generics are increasingly vital for expanding global healthcare access. Manufacturers able to prioritize quality, adapt sourcing, and refine commercial strategies will secure sustainable growth and resilient positioning as market dynamics shift and mature.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Branded Generics Market, by Dosage Form
8.1. Injections
8.1.1. Intramuscular
8.1.2. Intravenous
8.1.3. Subcutaneous
8.2. Liquids
8.2.1. Suspensions
8.2.2. Syrups
8.3. Tablets & Capsules
8.3.1. Extended Release
8.3.2. Immediate Release
8.4. Topicals
8.4.1. Creams
8.4.2. Gels
8.4.3. Ointments
9. Branded Generics Market, by Therapeutic Area
9.1. Anti-Infectives
9.1.1. Antibiotics
9.1.2. Antifungals
9.1.3. Antivirals
9.2. Cardiovascular
9.2.1. Anti-Dyslipidemics
9.2.2. Anti-Hypertensives
9.3. Central Nervous System
9.3.1. Anti-Depressants
9.3.2. Anti-Epileptics
9.3.3. Anti-Psychotics
9.4. Gastrointestinal
9.4.1. Antacids
9.4.2. Laxatives
9.5. Pain Management
9.5.1. Non-Opioid Analgesics
9.5.2. Opioids
10. Branded Generics Market, by Application
10.1. Animal Health
10.1.1. Companion Animals
10.1.1.1. Cats
10.1.1.2. Dogs
10.1.2. Livestock
10.2. Human Health
11. Branded Generics Market, by Distribution Channel
11.1. Drug Stores
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.3.1. Mobile App Pharmacies
11.3.2. Website Pharmacies
11.4. Retail Pharmacies
11.4.1. Chain Pharmacies
11.4.2. Independent Pharmacies
12. Branded Generics Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Branded Generics Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Branded Generics Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Branded Generics Market
16. China Branded Generics Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Amneal Pharmaceuticals LLC
17.6. Apotex Inc.
17.7. Aspen Pharmacare Holdings Limited
17.8. AstraZeneca PLC
17.9. Aurobindo Pharma Limited
17.10. Bausch Health Companies Inc.
17.11. Cipla Limited
17.12. Dr. Reddy’s Laboratories Ltd.
17.13. Dr. Reddy’s Laboratories Ltd.
17.14. Endo International PLC
17.15. Eris Lifesciences Limited
17.16. Eva Pharma
17.17. Fresenius Kabi AG
17.18. GlaxoSmithKline PLC
17.19. Glenmark Pharmaceuticals Limited
17.20. Hetero Drugs Limited
17.21. Lupin Limited
17.22. Mylan N.V. by Viatris Inc.
17.23. Sandoz International GmbH by Novartis Group
17.24. Sun Pharmaceutical Industries Ltd.
17.25. Teva Pharmaceutical Industries Ltd.
List of Figures
FIGURE 1. GLOBAL BRANDED GENERICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BRANDED GENERICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BRANDED GENERICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BRANDED GENERICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BRANDED GENERICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BRANDED GENERICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES BRANDED GENERICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA BRANDED GENERICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BRANDED GENERICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BRANDED GENERICS MARKET SIZE, BY INJECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BRANDED GENERICS MARKET SIZE, BY INJECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BRANDED GENERICS MARKET SIZE, BY INJECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BRANDED GENERICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BRANDED GENERICS MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BRANDED GENERICS MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BRANDED GENERICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BRANDED GENERICS MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BRANDED GENERICS MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BRANDED GENERICS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BRANDED GENERICS MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BRANDED GENERICS MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BRANDED GENERICS MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BRANDED GENERICS MARKET SIZE, BY LIQUIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BRANDED GENERICS MARKET SIZE, BY LIQUIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BRANDED GENERICS MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BRANDED GENERICS MARKET SIZE, BY SUSPENSIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BRANDED GENERICS MARKET SIZE, BY SUSPENSIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BRANDED GENERICS MARKET SIZE, BY SYRUPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BRANDED GENERICS MARKET SIZE, BY SYRUPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BRANDED GENERICS MARKET SIZE, BY SYRUPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BRANDED GENERICS MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BRANDED GENERICS MARKET SIZE, BY EXTENDED RELEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BRANDED GENERICS MARKET SIZE, BY EXTENDED RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BRANDED GENERICS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BRANDED GENERICS MARKET SIZE, BY IMMEDIATE RELEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BRANDED GENERICS MARKET SIZE, BY IMMEDIATE RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BRANDED GENERICS MARKET SIZE, BY TOPICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BRANDED GENERICS MARKET SIZE, BY TOPICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BRANDED GENERICS MARKET SIZE, BY TOPICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BRANDED GENERICS MARKET SIZE, BY CREAMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BRANDED GENERICS MARKET SIZE, BY CREAMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BRANDED GENERICS MARKET SIZE, BY CREAMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BRANDED GENERICS MARKET SIZE, BY GELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BRANDED GENERICS MARKET SIZE, BY GELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BRANDED GENERICS MARKET SIZE, BY GELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BRANDED GENERICS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BRANDED GENERICS MARKET SIZE, BY OINTMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BRANDED GENERICS MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTIFUNGALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTIFUNGALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTIVIRALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTIVIRALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-DYSLIPIDEMICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-DYSLIPIDEMICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-DYSLIPIDEMICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-HYPERTENSIVES, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-HYPERTENSIVES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-HYPERTENSIVES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-DEPRESSANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-DEPRESSANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-DEPRESSANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-EPILEPTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-EPILEPTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-EPILEPTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-PSYCHOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-PSYCHOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-PSYCHOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTACIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTACIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTACIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BRANDED GENERICS MARKET SIZE, BY LAXATIVES, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BRANDED GENERICS MARKET SIZE, BY LAXATIVES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BRANDED GENERICS MARKET SIZE, BY LAXATIVES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BRANDED GENERICS MARKET SIZE, BY NON-OPIOID ANALGESICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BRANDED GENERICS MARKET SIZE, BY NON-OPIOID ANALGESICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL BRANDED GENERICS MARKET SIZE, BY NON-OPIOID ANALGESICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL BRANDED GENERICS MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL BRANDED GENERICS MARKET SIZE, BY OPIOIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL BRANDED GENERICS MARKET SIZE, BY OPIOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL BRANDED GENERICS MARKET SIZE, BY CATS, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL BRANDED GENERICS MARKET SIZE, BY CATS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL BRANDED GENERICS MARKET SIZE, BY CATS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL BRANDED GENERICS MARKET SIZE, BY DOGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL BRANDED GENERICS MARKET SIZE, BY DOGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL BRANDED GENERICS MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL BRANDED GENERICS MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL BRANDED GENERICS MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL BRANDED GENERICS MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL BRANDED GENERICS MARKET SIZE, BY HUMAN HEALTH, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL BRANDED GENERICS MARKET SIZE, BY HUMAN HEALTH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL BRANDED GENERICS MARKET SIZE, BY HUMAN HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL BRANDED GENERICS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL BRANDED GENERICS MARKET SIZE, BY DRUG STORES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL BRANDED GENERICS MARKET SIZE, BY DRUG STORES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL BRANDED GENERICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL BRANDED GENERICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL BRANDED GENERICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL BRANDED GENERICS MARKET SIZE, BY MOBILE APP PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL BRANDED GENERICS MARKET SIZE, BY MOBILE APP PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL BRANDED GENERICS MARKET SIZE, BY MOBILE APP PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL BRANDED GENERICS MARKET SIZE, BY WEBSITE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL BRANDED GENERICS MARKET SIZE, BY WEBSITE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL BRANDED GENERICS MARKET SIZE, BY WEBSITE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL BRANDED GENERICS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL BRANDED GENERICS MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL BRANDED GENERICS MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL BRANDED GENERICS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL BRANDED GENERICS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL BRANDED GENERICS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL BRANDED GENERICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 155. AMERICAS BRANDED GENERICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 156. AMERICAS BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 157. AMERICAS BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2018-2032 (USD MILLION)
TABLE 158. AMERICAS BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2018-2032 (USD MILLION)
TABLE 159. AMERICAS BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
TABLE 160. AMERICAS BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 161. AMERICAS BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 162. AMERICAS BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
TABLE 163. AMERICAS BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 164. AMERICAS BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 165. AMERICAS BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 166. AMERICAS BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 167. AMERICAS BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 168. AMERICAS BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 169. AMERICAS BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 170. AMERICAS BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 171. AMERICAS BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 172. AMERICAS BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 173. NORTH AMERICA BRANDED GENERICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. NORTH AMERICA BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 175. NORTH AMERICA BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2018-2032 (USD MILLION)
TABLE 176. NORTH AMERICA BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2018-2032 (USD MILLION)
TABLE 177. NORTH AMERICA BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
TABLE 178. NORTH AMERICA BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 179. NORTH AMERICA BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 180. NORTH AMERICA BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
TABLE 181. NORTH AMERICA BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 182. NORTH AMERICA BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 183. NORTH AMERICA BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 184. NORTH AMERICA BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 185. NORTH AMERICA BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 186. NORTH AMERICA BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 187. NORTH AMERICA BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 188. NORTH AMERICA BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 189. NORTH AMERICA BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 190. NORTH AMERICA BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 191. LATIN AMERICA BRANDED GENERICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. LATIN AMERICA BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 193. LATIN AMERICA BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2018-2032 (USD MILLION)
TABLE 194. LATIN AMERICA BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2018-2032 (USD MILLION)
TABLE 195. LATIN AMERICA BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
TABLE 196. LATIN AMERICA BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 197. LATIN AMERICA BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 198. LATIN AMERICA BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
TABLE 199. LATIN AMERICA BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 200. LATIN AMERICA BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 201. LATIN AMERICA BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 202. LATIN AMERICA BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 203. LATIN AMERICA BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 204. LATIN AMERICA BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 205. LATIN AMERICA BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 206. LATIN AMERICA BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 207. LATIN AMERICA BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 208. LATIN AMERICA BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2018-2032 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2018-2032 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 227. EUROPE BRANDED GENERICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 228. EUROPE BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 229. EUROPE BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2018-2032 (USD MILLION)
TABLE 230. EUROPE BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2018-2032 (USD MILLION)
TABLE 231. EUROPE BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
TABLE 232. EUROPE BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 233. EUROPE BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 234. EUROPE BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
TABLE 235. EUROPE BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 236. EUROPE BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 237. EUROPE BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 238. EUROPE BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 239. EUROPE BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 240. EUROPE BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 241. EUROPE BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 242. EUROPE BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 243. EUROPE BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 244. EUROPE BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 245. MIDDLE EAST BRANDED GENERICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 246. MIDDLE EAST BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 247. MIDDLE EAST BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2018-2032 (USD MILLION)
TABLE 248. MIDDLE EAST BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2018-2032 (USD MILLION)
TABLE 249. MIDDLE EAST BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
TABLE 250. MIDDLE EAST BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 251. MIDDLE EAST BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 252. MIDDLE EAST BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
TABLE 253. MIDDLE EAST BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 254. MIDDLE EAST BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 255. MIDDLE EAST BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 256. MIDDLE EAST BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 257. MIDDLE EAST BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 258. MIDDLE EAST BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 259. MIDDLE EAST BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 260. MIDDLE EAST BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 261. MIDDLE EAST BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 262. MIDDLE EAST BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 263. AFRICA BRANDED GENERICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 264. AFRICA BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 265. AFRICA BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2018-2032 (USD MILLION)
TABLE 266. AFRICA BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2018-2032 (USD MILLION)
TABLE 267. AFRICA BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
TABLE 268. AFRICA BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 269. AFRICA BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 270. AFRICA BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
TABLE 271. AFRICA BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 272. AFRICA BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 273. AFRICA BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 274. AFRICA BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 275. AFRICA BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 276. AFRICA BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 277. AFRICA BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 278. AFRICA BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 279. AFRICA BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 280. AFRICA BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 281. ASIA-PACIFIC BRANDED GENERICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 282. ASIA-PACIFIC BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 283. ASIA-PACIFIC BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2018-2032 (USD MILLION)
TABLE 284. ASIA-PACIFIC BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2018-2032 (USD MILLION)
TABLE 285. ASIA-PACIFIC BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
TABLE 286. ASIA-PACIFIC BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 287. ASIA-PACIFIC BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 288. ASIA-PACIFIC BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
TABLE 289. ASIA-PACIFIC BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 290. ASIA-PACIFIC BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 291. ASIA-PACIFIC BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 292. ASIA-PACIFIC BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 293. ASIA-PACIFIC BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 294. ASIA-PACIFIC BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 295. ASIA-PACIFIC BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 296. ASIA-PACIFIC BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 297. ASIA-PACIFIC BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 298. ASIA-PACIFIC BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 299. GLOBAL BRANDED GENERICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 300. ASEAN BRANDED GENERICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 301. ASEAN BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 302. ASEAN BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2018-2032 (USD MILLION)
TABLE 303. ASEAN BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2018-2032 (USD MILLION)
TABLE 304. ASEAN BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
TABLE 305. ASEAN BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 306. ASEAN BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 307. ASEAN BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
TABLE 308. ASEAN BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 309. ASEAN BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 310. ASEAN BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 311. ASEAN BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 312. ASEAN BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 313. ASEAN BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 314. ASEAN BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 315. ASEAN BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 316. ASEAN BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 317. ASEAN BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 318. GCC BRANDED GENERICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 319. GCC BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 320. GCC BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2018-2032 (USD MILLION)
TABLE 321. GCC BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2018-2032 (USD MILLION)
TABLE 322. GCC BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
TABLE 323. GCC BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2018-2032 (USD MILLION)
TABLE 324. GCC BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 325. GCC BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
TABLE 326. GCC BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 327. GCC BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 328. GCC BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 329. GCC BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 330. GCC BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 331. GCC BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 332. GCC BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 333. GCC BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 334. GCC BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 335. GCC BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 336. EUROPEAN UNION BRANDED GENERICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 337. EUROPEAN UNION BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 338. EUROPEAN UNION BRAND

Companies Mentioned

The key companies profiled in this Branded Generics market report include:
  • Amneal Pharmaceuticals LLC
  • Apotex Inc.
  • Aspen Pharmacare Holdings Limited
  • AstraZeneca PLC
  • Aurobindo Pharma Limited
  • Bausch Health Companies Inc.
  • Cipla Limited
  • Dr. Reddy’s Laboratories Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Endo International PLC
  • Eris Lifesciences Limited
  • Eva Pharma
  • Fresenius Kabi AG
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Limited
  • Hetero Drugs Limited
  • Lupin Limited
  • Mylan N.V. by Viatris Inc.
  • Sandoz International GmbH by Novartis Group
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages185
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 652.14 Billion
Forecasted Market Value ( USD ) by 2032 $ 1520 Billion
Compound Annual Growth Rate15.1%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Branded Generics - Global Strategic Business Report - Product Image

Branded Generics - Global Strategic Business Report

  • Report
  • 354 Pages
  • Global
From
Branded Generics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Branded Generics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 190 Pages
  • Global
From
Branded Generics Market Report 2025 - Product Image

Branded Generics Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Branded Generics: Market Share, and Growth Analysis by Product Type (Tablets, Capsules, Liquids), Application, End User, Technology - Product Image

Branded Generics: Market Share, and Growth Analysis by Product Type (Tablets, Capsules, Liquids), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
2025 Global Forecast for Branded Generics (2026-2031 Outlook)-High Tech Outlook Report - Product Image

2025 Global Forecast for Branded Generics (2026-2031 Outlook)-High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From

About the Branded Generics Market

Branded generics are generic drugs that are marketed under a brand name. They are typically manufactured by a generic drug company, but are sold under a brand name owned by a pharmaceutical company. Branded generics are typically sold at a higher price than generic drugs, but are still much cheaper than the original brand-name drug. They are often used to increase the market share of a generic drug company, as well as to increase the visibility of a generic drug in the marketplace. Branded generics are becoming increasingly popular in the pharmaceutical industry, as they offer a cost-effective alternative to brand-name drugs. They are also used to increase the market share of generic drug companies, as well as to increase the visibility of generic drugs in the marketplace. Some companies in the branded generics market include Teva Pharmaceuticals, Mylan, Sandoz, and Dr. Reddy's Laboratories. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.